Asthma is a chronic inflammatory disease of the airways characterized by th
e local production of inflammatory mediators and an increase in recruitment
of inflammatory cells (predominantly eosinophils and mast cells), It has b
een proposed that the chronic nature of this inflammatory response may be r
esponsible for long-term pulmonary changes including bronchial hyperrespons
iveness, airway remodeling, and irreversible airflow obstruction. Much of t
he information available on the pathogenesis of asthma is based on studies
performed in young adults. Because of numerous complications, studies in in
fants and young children are often difficult to conduct; therefore informat
ion on this age group is lacking, Although studies are limited, data sugges
t that an asthma-like inflammation is present at a very early age, with inc
reases in inflammatory cells and thickening of the lung basement membrane d
etected in infants and young children, In addition, lung function of childr
en with persistent wheezing was significantly lower by 6 years of age compa
red with children who had no wheezing episodes during the same period; diff
erences between groups were not apparent at 6 months of age. These data sug
gest that airway inflammation in young children with asthma is associated w
ith nonreversible impairment of lung function. Recent National Asthma Educa
tion and Prevention Guidelines stress the importance of anti-inflammatory a
gents, particularly inhaled corticosteroids, in the treatment of young chil
dren with persistent asthma, Given data supporting the presence of an infla
mmatory response early in the disease course, early intervention with anti-
inflammatory agents may be indicated at the onset of symptoms to prevent lo
ng-term, irreversible, impairment of lung function. Although several studie
s have shown that inhaled corticosteroids may be effective in the treatment
of recurrent wheezing in infancy, tools need to be developed to distinguis
h infants with early-onset asthma from those with transient wheezing.